Header Logo

Connection

Beverly Sha to Drug Resistance, Viral

Back to Details
This is a "connection" page, showing publications Beverly Sha has written about Drug Resistance, Viral.
Beverly Sha
Connection Strength
0.041
Drug Resistance, Viral
  1. Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500?000 copies/mL: week 48 outcomes from ACTG 5353. J Antimicrob Chemother. 2019 05 01; 74(5):1376-1380.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.